Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2008
12/18/2008WO2008016968A3 Non-flushing niacin analogues, and methods of use thereof
12/18/2008WO2008008732A3 Substituted aminopyridines as fluorescent reporters for amide hydrolases
12/18/2008US20080312450 Method for Start-Up of Oxidation Catalysts
12/18/2008US20080312449 New Compounds
12/18/2008US20080312446 Imaging agents for diagnosis of parkinson's disease
12/18/2008US20080312435 Imine Compound
12/18/2008US20080312298 Methods for Identification of Modulators of Carm1 Methyl Transferase Activity
12/18/2008US20080312297 such as N-methoxy-N'-(2-chloropyrid-5-ylmethyl)nitroguanidine, formed by reacting N-nitro-N'-(2-chloropyrid-5-ylmethyl)-S-methylisothiourea and O-methylhydroxylamine; pesticides; insecticides
12/18/2008US20080312294 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4 beta ,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; glucocorticoid receptor modulators; antiinflammatory agents; Alzheimer's disease; side effect reduction
12/18/2008US20080312293 2-Arylpropionic Acid Derivatives and Pharmaceutical Compositions Containing Them
12/18/2008US20080312292 Antipruritics
12/18/2008US20080312286 Indanone Potentiators of Metabotropic Glutamate Receptors
12/18/2008US20080312284 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridine-2-one; antagonistic action against AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor and/or inhibitory action against kainate receptor prophylactic agent for neurodegenerative diseases
12/18/2008US20080312262 Such as 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)oxy]ethyl}carbamate; sleep disorders
12/18/2008US20080312244 Squaric Acid Derivatives as Protein Kinase Inhibitors
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080312234 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
12/18/2008US20080312207 Compounds
12/18/2008US20080312161 Compounds For Stabilizing Factor VII Polypeptide Formulations
12/18/2008US20080311113 Method for treating adamts-5-associated disease
12/18/2008CA2691987A1 Antibacterial agents
12/18/2008CA2690913A1 Ire-1alpha inhibitors
12/18/2008CA2690265A1 Mutual prodrugs and methods to treat cancer
12/17/2008EP2003120A1 Azapeptide derivatives as HIV protease inhibitors
12/17/2008EP2003116A2 Process for the production of organic oxides
12/17/2008EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/17/2008EP2001873A1 Active ingredient combinations with insecticidal properties
12/17/2008EP2001851A2 Amide derivatives and their application for the treament of g protein related diseases
12/17/2008EP2001850A1 Process for preparing 6,7-dihydro-5h-imidazoý1,5-a¨pyridin-8-one
12/17/2008EP2001849A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
12/17/2008EP2001838A2 Selective hydroxamate based mmp inhibitors
12/17/2008EP2001830A1 Glyceride ester derivatives of herbicidal compounds and compositions thereof
12/17/2008EP1917233B1 Anilinohexafluoroisopropanol compounds
12/17/2008EP1773763B1 Lysine based compounds
12/17/2008EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases
12/17/2008EP1077943B1 Heterocyclic inhibitors of p38
12/17/2008CN101326161A Novel compounds
12/17/2008CN100443475C Compound of 2-substituted alkylacrylate and application thereof
12/17/2008CN100443471C Chemical synthesis method of 4-amino-3,5,6-trichloropyridine-2-formic acid
12/17/2008CN100443467C Substituted aromatic amide derivative intemediate thereof, agrohorticultral insecticide containing thereof and method for use thereof
12/16/2008US7465803 Nitroderivatives as drugs for diseases having an inflammatory basis
12/16/2008US7465802 Grignard reagent (such as 4-alkylphenylmagnesium bromide) is added to a 3-cyanopyridinium salt (such as N-phenyloxycarbonyl-3-cyanopyridinium chloride) to get a 1,2-dihydropyridine which is oxidized with o-chloronil to obtain the 2-(4'-alkylphenyl)-5-cyanopyridine; display system
12/16/2008US7465801 Process to prepare pioglitazone via several novel intermediates
12/16/2008US7465747 Fluorescent label compounds
12/16/2008CA2302937C Method for producing (hetero)aromatic hydroxylamines
12/11/2008WO2008149965A1 Pyridone compound
12/11/2008WO2008149181A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
12/11/2008WO2008148853A1 N-phenyl hydrazides as modulators of the ghrelin receptor
12/11/2008WO2008148747A2 Pdz domain modulators
12/11/2008WO2008148468A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/11/2008WO2008023171A3 Ionic additive for catalysis in biphasic reaction systems
12/11/2008WO2007143327A3 Methods of nanoassembly of a fractal polymer and materials formed thereby
12/11/2008US20080306278 Process
12/11/2008US20080306276 Facile synthesis of a series of liquid crystalline 2-(4'-alkoxyphenyl)-5-cyanopyridines
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306136 Substituted Ureas and Carbamates
12/11/2008US20080306108 Substituted Pyridoxines As Anti-Platelet Agents
12/11/2008US20080306107 Compounds
12/11/2008US20080306085 Non-imidazole aryloxyalkylamines
12/11/2008US20080306066 Non-imidazole heterocyclic compounds
12/11/2008US20080305049 Mri Contrast Agents for Diagnosis and Prognosis of Tumors
12/11/2008DE112007000299T5 Verfahren zur Herstellung von aromatischer Verbindung Process for the preparation of aromatic compound
12/11/2008CA2693552A1 Pyridone compound
12/11/2008CA2691446A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
12/11/2008CA2690004A1 Tri-aryl compounds and compositions comprising the same
12/11/2008CA2689985A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/10/2008EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
12/10/2008EP1999111A2 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
12/10/2008EP1999110A2 PROCESS FOR PREPARING l-HALO-2,7-NAPHTHYRIDINYL DERIVATIVES
12/10/2008EP1999109A2 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
12/10/2008EP1998761A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/10/2008EP1511730B1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/10/2008EP1396487B1 Phenylpyridine carbonyl piperazine derivative
12/10/2008EP1391199B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
12/10/2008EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/10/2008CN101321751A Met kinase inhibitors
12/10/2008CN101321731A Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
12/10/2008CN101318953A Insecticidal activity compound
12/10/2008CN101318929A Synthesis process for chromium picolinate
12/10/2008CN101318928A Process for the separation of 2-hydroxymethyl-3, 5-dimethyl-4-methoxy pyridine
12/10/2008CN101318927A Method for producing substituted phenylsulfonyl urea
12/09/2008US7462716 Statin derivatives
12/09/2008US7462689 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
12/09/2008US7462634 N-(pyridin-2-yl)-sulfonamide derivatives
12/09/2008US7462621 9-[3-(2-Fluorophenyl)-propyl]-7,7-dimethyl-2-(pyridin-4-yl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; neurodegenerative disease caused by abnormal activity of GSK3 beta (glycogen synthase kinase beta 3) or GSK3 beta and cdk5/p253
12/09/2008US7462619 Pyridazine, pyrimidine and pyrazine ethyne compounds
12/09/2008US7462617 Substituted acylpiperazine derivatives
12/09/2008US7462608 Non nucleoside reverse transcriptase inhibitors
12/09/2008CA2379061C Antibacterial agents
12/09/2008CA2321254C Pyradazine derivatives having inhibitory activity against interleukin-1.beta. production
12/04/2008WO2008147170A1 New process of synthesis for obtaining 5-methyl-1-phenyl-2 (ih) -pyridone, composition and use of the same
12/04/2008WO2008145842A2 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/04/2008WO2008145785A1 Method for electrochemical detection of sequences of nucleic acids
12/04/2008WO2008145616A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
12/04/2008WO2008144933A1 Cinnamoyl inhibitors of transglutaminase
12/04/2008WO2008094992A3 2-aminopyridine derivatives useful as kinase inhibitors
12/04/2008WO2008016956A3 Methods for manufacturing ary-aryl coupled polymers
12/04/2008WO2006073973A3 Novel benzylamine derivatives as cetp inhibitors
12/04/2008US20080300348 Polymer
12/04/2008US20080300282 Coupling thiazolidine-2,4-dione with p-(2-alkylpyridyl-2-hydroxy-, Cl-, Br-, mesyl- or tosyl-ethoxybenzaldehyde in a solvent, an organic base and an organic acid catalyst and hydrogenating the product to form 5-[4-[2-(alkylpyridyl)2-hydroxy-, Cl-, Br-, mesyl- or tosylethoxy]benzyl-2,4-thiazolidinedione
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 633